Search research articles
Contact Us
Filters
Showing results (691-700 of 873) with videos related to
Page
of 88
Sort By:
American Journal of Industrial Medicine
|
October 12, 2011
Coal mining is associated with lung cancer risk in Xuanwei, China
H Dean Hosgood, Robert S Chapman, Hu Wei, et al.
Annals of Work Exposures and Health
|
September 16, 2020
Modeled Air Pollution from In Situ Burning and Flaring of Oil and Gas Released Following the Deepwater Horizon Disaster
Gregory C Pratt, Mark R Stenzel, Richard K Kwok, et al.
Nature Communications
|
September 27, 2024
Optically accessible long-lived electronic biexcitons at room temperature in strongly coupled H- aggregates
Siddhartha Sohoni, Indranil Ghosh, Geoffrey T Nash, et al.
Alimentary Pharmacology & Therapeutics
|
February 21, 2025
Clinical Trial: A Phase 2b Study to Evaluate the Efficacy and Safety of MK-3655 in Individuals With Pre-Cirrhotic MASH
Annaswamy Raji, Ira Gantz, Michael Crutchlow, et al.
Current Medical Research and Opinion
|
February 15, 2019
Results of VERTIS SU extension study: safety and efficacy of ertugliflozin treatment over 104 weeks compared to glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin
Priscilla Hollander, Julie Hill, Jeremy Johnson, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
December 29, 2017
Ertugliflozin Compared with Glimepiride in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: The VERTIS SU Randomized Study
Priscilla Hollander, Jie Liu, Julie Hill, et al.
International Journal of Clinical Practice
|
August 19, 2011
Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs. pioglitazone in drug-naïve patients with type 2 diabetes
A Pérez-Monteverde, T Seck, L Xu, et al.
Diabetes Research and Clinical Practice
|
October 29, 2017
A randomized, double-blind trial evaluating the efficacy and safety of monotherapy with the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in people with type 2 diabetes
Philip Home, R Ravi Shankar, Ira Gantz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 24, 2007
Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancers
Joan Fortuny, Christine C Johnson, Kari Bohlke, et al.
The Journal of Physical Chemistry Letters
|
April 11, 2014
Persistent Inter-Excitonic Quantum Coherence in CdSe Quantum Dots
Justin R Caram, Haibin Zheng, Peter D Dahlberg, et al.
Page
of 88
Search research articles
Search
Showing results (691-700 of 873) with videos related to
Sort By:
Page
of 88
American Journal of Industrial Medicine
|
October 12, 2011
Coal mining is associated with lung cancer risk in Xuanwei, China
H Dean Hosgood, Robert S Chapman, Hu Wei, et al.
Annals of Work Exposures and Health
|
September 16, 2020
Modeled Air Pollution from In Situ Burning and Flaring of Oil and Gas Released Following the Deepwater Horizon Disaster
Gregory C Pratt, Mark R Stenzel, Richard K Kwok, et al.
Nature Communications
|
September 27, 2024
Optically accessible long-lived electronic biexcitons at room temperature in strongly coupled H- aggregates
Siddhartha Sohoni, Indranil Ghosh, Geoffrey T Nash, et al.
Alimentary Pharmacology & Therapeutics
|
February 21, 2025
Clinical Trial: A Phase 2b Study to Evaluate the Efficacy and Safety of MK-3655 in Individuals With Pre-Cirrhotic MASH
Annaswamy Raji, Ira Gantz, Michael Crutchlow, et al.
Current Medical Research and Opinion
|
February 15, 2019
Results of VERTIS SU extension study: safety and efficacy of ertugliflozin treatment over 104 weeks compared to glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin
Priscilla Hollander, Julie Hill, Jeremy Johnson, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
December 29, 2017
Ertugliflozin Compared with Glimepiride in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: The VERTIS SU Randomized Study
Priscilla Hollander, Jie Liu, Julie Hill, et al.
International Journal of Clinical Practice
|
August 19, 2011
Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs. pioglitazone in drug-naïve patients with type 2 diabetes
A Pérez-Monteverde, T Seck, L Xu, et al.
Diabetes Research and Clinical Practice
|
October 29, 2017
A randomized, double-blind trial evaluating the efficacy and safety of monotherapy with the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in people with type 2 diabetes
Philip Home, R Ravi Shankar, Ira Gantz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 24, 2007
Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancers
Joan Fortuny, Christine C Johnson, Kari Bohlke, et al.
The Journal of Physical Chemistry Letters
|
April 11, 2014
Persistent Inter-Excitonic Quantum Coherence in CdSe Quantum Dots
Justin R Caram, Haibin Zheng, Peter D Dahlberg, et al.
Page
of 88